DrugPatentWatch Database Preview

VASOSTRICT Drug Profile

« Back to Dashboard

When do Vasostrict patents expire, and when can generic versions of Vasostrict launch?

Vasostrict is a drug marketed by Par Sterile Products and is included in one NDA. There are six patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in VASOSTRICT is vasopressin. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the vasopressin profile page.

Summary for VASOSTRICT

US Patents:	6
Applicants:	1
NDAs:	1
Suppliers / Packagers:	3
Bulk Api Vendors:	3
Clinical Trials:	1
Patent Applications:	2
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for VASOSTRICT
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for VASOSTRICT
DailyMed Link:	VASOSTRICT at DailyMed

Generic Entry Opportunity Date for VASOSTRICT

NDA:

204485

Dosage:

SOLUTION;IV (INFUSION)

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for VASOSTRICT

11034-16-5

12678-42-1

196116-EP2272972A1

196116-EP2272973A1

196116-EP2277872A1

ADH (hormone)

AM012156

EINECS 234-236-2

HSDB 3412

Intertocin

Inyectable de vasopresina [INN-Spanish]

Pitressin (TN)

Pituitrin

Pituitrin P

SCHEMBL1172390

Solute injectable de vasopressine [INN-French]

Tonephin

UNII-Y87Y826H08

Vasopressin (JP17/USP)

Vasopressin, unspecified

Vasopressina

Vasopressina [DCIT]

Vasopressine

Vasopressini injectio [INN-Latin]

Vasopressins

Vasopressinum

Y87Y826H08

US Patents and Regulatory Information for VASOSTRICT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Par Sterile Products	VASOSTRICT	vasopressin	SOLUTION;IV (INFUSION)	204485-001	Apr 17, 2014		RX	Yes	Yes			Y
Par Sterile Products	VASOSTRICT	vasopressin	SOLUTION;IV (INFUSION)	204485-002	Dec 17, 2016		RX	Yes	Yes
Par Sterile Products	VASOSTRICT	vasopressin	SOLUTION;IV (INFUSION)	204485-001	Apr 17, 2014		RX	Yes	Yes
Par Sterile Products	VASOSTRICT	vasopressin	SOLUTION;IV (INFUSION)	204485-002	Dec 17, 2016		RX	Yes	Yes
Par Sterile Products	VASOSTRICT	vasopressin	SOLUTION;IV (INFUSION)	204485-001	Apr 17, 2014		RX	Yes	Yes
Par Sterile Products	VASOSTRICT	vasopressin	SOLUTION;IV (INFUSION)	204485-001	Apr 17, 2014		RX	Yes	Yes
Par Sterile Products	VASOSTRICT	vasopressin	SOLUTION;IV (INFUSION)	204485-002	Dec 17, 2016		RX	Yes	Yes			Y

Paragraph IV (Patent) Challenges for VASOSTRICT

Drugname	Dosage	Strength	RLD	Date
	Injection	20 units/mL, 1 mL